News
Euphoria star Eric Dane has announced that he was diagnosed with a rare degenerative disease named Amyotrophic Lateral ...
Euphoria star Eric Dane has revealed that he was diagnosed with a rare degenerative disease, Amyotrophic Lateral Sclerosis ...
The early signs of Motor Neurone Disease (MND) and ALS can be subtle and often vary depending on which motor neurons are ...
The 52-year-old actor announced he was diagnosed with the progressive and terminal disease in a statement. Eric Dane has been diagnosed with amyotrophic lateral sclerosis (ALS). The 52-year-old actor ...
PrimeC has demonstrated promising results in the 18-month Phase 2b trial, with data highlighting its potential as a disease-modifying therapy for ALS. The trial revealed a marked reduction in ALS ...
NeuroSense has made notable progress in aligning its Phase 3 study design with the FDA, with plans to initiate the trial in 2025. The company is currently exploring partnership opportunities to ...
Eric Dane has been diagnosed with amyotrophic lateral sclerosis (ALS), a progressive neurological disease. He is married to ...
BrainStorm has attempted to gain market approval for NurOwn without success but remains committed to developing the cell therapy.
BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading biotechnology company developing cutting-edge cell therapies ...
Verge Genomics will use digital biomarkers to assess short-term disease progression in an ALS trial testing its VRG50635 ...
BrainStorm (BCLI) submitted an Investigational New Drug, or IND, amendment to the FDA for NurOwn, the company’s autologous mesenchymal stem ...
BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading biotechnology company developing cutting-edge cell therapies for neurodegenerative diseases, today announced the submission of an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results